PRESENT AND FUTURE

Clinical pathways, today and on the horizon.

Three indications with preventive, longevity and family health intelligence on the roadmap.

Algocyte Proxima in clinical use

SOON

Phase 1.

Three indications where more regular testing can support earlier intervention.

On the roadmap

Next phase.

Preventive health, chronic disease, longevity, family health intelligence and home healthcare programmes on our roadmap.

Bring regular precision and predictive monitoring to users and patients.

See Algocyte in action.